The Cooper Companies, Inc. (COO)
| Market Cap | 19.11B |
| Revenue (ttm) | 2.47B |
| Net Income (ttm) | 2.25B |
| Shares Out | 49.10M |
| EPS (ttm) | 45.38 |
| PE Ratio | 8.57 |
| Forward PE | 31.15 |
| Dividend | $0.06 |
| Dividend Yield | 0.02% |
| Trading Day | May 18 |
| Last Price | $388.77 |
| Previous Close | $388.22 |
| Change ($) | 0.55 |
| Change (%) | 0.14% |
| Day's Open | 388.50 |
| Day's Range | 385.97 - 392.91 |
| Day's Volume | 136,297 |
| 52-Week Range | 268.87 - 415.96 |
SAN RAMON, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has elected Dr. Maria Rivas as an independent director, effective July 1, 2021.
SAN RAMON, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that CooperSurgical has acquired obp Medical Corporation, a U.S. based medical device company that develo...
SAN RAMON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release second quarter 2021 financial results on Thursday, June 3, 2021, at 4:15 PM ET. Followi...
According to the Peter Lynch Growth Screen, a Premium All-in-One Screener template, five stocks with high financial strength, good revenue growth and are trading below the Peter Lynch earnings line as o...
The Cooper Companies (COO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Robert S. Weiss named Chairman of the Board and William A. Kozy named Vice Chairman and Lead Director Robert S. Weiss named Chairman of the Board and William A. Kozy named Vice Chairman and Lead Director
Cooper Companies' (COO) unit assigns smart glasses to boost productivity in operations.
Cooper Companies (COO) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
Value investors may be interested in the following three stocks since their share prices are trading below their respective Peter Lynch earnings lines, indicating they could be undervalued. Sell-side an...
Investors remain optimistic about Cooper Companies (COO) backed by strong CSI and CVI product portfolios and its continued leadership in the specialty lenses market.
According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned health care stocks have grown their book value per share over the past decade through March 11.
Cooper Companies (COO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa...
Cooper Companies' (COO) fiscal first-quarter earnings reflect solid segmental performance.
Cooper Cos. (COO) delivered earnings and revenue surprises of 14.44% and 3.10%, respectively, for the quarter ended January 2021.
Shares of Cooper Companies (NYSE:COO) fell 2.6% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 17.84% year over year to $3.17, which beat the es...
SAN RAMON, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal first quarter ended January 31, 2021.
Cooper Companies (NYSE:COO) releases its next round of earnings this Thursday, March 04. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
SAN RAMON, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021. Brian Andrews, Execu...
Cooper Companies' (COO) fiscal first-quarter results are likely to reflect strength at MiSight 1-day contact lens.
SAN RAMON, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that CooperSurgical has acquired Safe Obstetric Systems, a privately held manufacturer of the medical d...
SAN RAMON, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021. Daniel McBride, Esq,...
LOS ANGELES--(BUSINESS WIRE)---- $COO #COO--Angeles Equity Partners Names Annie Chau Chief Operating and Compliance Officer
SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET. Follow...
CHARENTON-LE-PONT, France, and SAN RAMON, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- EssilorLuxottica and CooperCompanies, two of the world's leading vision care companies, have entered into an agreement...
Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Cooper Companies (COO) arm's buyout drives its growing portfolio of medical products, which revolves around clinic and practice-based women's healthcare
Employees give company culture high marks for fairness, respect, and pride Employees give company culture high marks for fairness, respect, and pride
SAN RAMON, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that consistent with the plan approved by its board of directors to pay annual dividends, the Company de...
Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.
SAN RAMON, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and CEO, will r...
SAN RAMON, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced that it will hold its next annual meeting of stockholders on Wednesday, March 17, 2021. Stockholders of re...
SAN RAMON, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) announced today that A. Thomas Bender and Allan E. Rubenstein, M.D. have decided to retire and will not stand for re-elect...
Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.
The Cooper Companies, Inc. (COO) CEO Al White on Q4 2020 Results - Earnings Call Transcript
Cooper Cos. (COO) delivered earnings and revenue surprises of 1.61% and 0.38%, respectively, for the quarter ended October 2020.
Shares of Cooper Companies (NYSE:COO) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 4.24% year over year to $3.16, which beat the est...
SAN RAMON, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2020.
Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Cooper Companies' (COO) fiscal fourth-quarter performance is likely to reflect better performance by CVI and CSI.
Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.
SAN RAMON, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors elected Teresa S. Madden to the Board as an independent director, effective D...
PDCO vs. COO: Which Stock Is the Better Value Option?
In this article we are going to use hedge fund sentiment as a tool and determine whether The Cooper Companies, Inc. (NYSE:COO) is a good investment right now. We like to analyze hedge fund sentiment bef...
SAN RAMON, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 2020, at 4:1...
After a 43% rise since the March 23 lows of this year, at the current price of around $348 per share we believe Cooper stock (NYSE: COO), best known for its Cooper Vision lenses, has reached its near-te...
About COO
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomi... [Read more...]
| Industry Medical Instruments & Supplies | Founded 1980 |
| CEO Albert White | Employees 12,000 |
| Stock Exchange NYSE | Ticker Symbol COO |
Financial Performance
In 2020, COO's revenue was $2.43 billion, a decrease of -8.39% compared to the previous year's $2.65 billion. Earnings were $238.40 million, a decrease of -48.92%.
Analyst Forecasts
According to 16 analysts, the average rating for COO stock is "Buy." The 12-month stock price forecast is 420.50, which is an increase of 8.16% from the latest price.